ReviewChildren (Basel, Switzerland)2026
Ontogenetic Immaturity of Urachal Structures and Its Clinical Implications for Conservative Management in Children.
Review in Children (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormalities of the urachus detected in infancy and early childhood are often interpreted as persistent congenital abnormalities requiring surgical correction. However, growing clinical experience suggests that a proportion of these findings may reflect ontogenetic immaturity of the urachus rather than fixed pathological conditions. As a transient embryological structure, the urachus undergoes postnatal remodeling and involution, which may explain the spontaneous regression of urachal anomalies observed during follow-up. This paper proposes ontogenetic immaturity of the urachus as a biological substrate for the natural resolution of selected urachal changes, including cystic dilatation and incomplete obliteration. We discuss the developmental background of urachal maturation and emphasize the importance of distinguishing delayed involution from true structural pathology. The clinical implications of this concept are highlighted, with particular focus on the role of careful observation and longitudinal monitoring as an alternative to early surgical intervention in asymptomatic or mildly symptomatic patients. Recognizing ontogenetic immaturity as a reversible developmental state may help reduce overtreatment and support more individualized, developmentally informed management strategies. Integrating principles of developmental biology into clinical decision-making reinforces the value of conservative approaches in selected urachal conditions and under-scores the broader relevance of ontogeny in kidney and urinary tract disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.